← Back to Articles
GLP-1 AGONISTS
Cagrilintide-semaglutide: a new option for patients with type 2 diabetes
Authors: André J Scheen
Journal: The lancet. Diabetes & endocrinology
Authors: André J Scheen
Journal: The lancet. Diabetes & endocrinology